• Nov
    14
    [3:00 PM - 4:00 PM]
    Would understanding the developmental history, genotypes, brain structure and functioning of your patients modify treatment choices and outcomes?
    Sheilagh Hodgins, Ph.D., F.R.S.C.[SUITE...]
  • Nov
    19
    [12:00 PM - 1:00 PM]
    Methylene blue inhibits Caspase-6 activity, and reverses Caspase-6-induced cognitive impairment and neuroinflammation in aged mice
    Libin Zhou, Ph.D. Student
    Dr. Andrea LeBla...
    [SUITE...]
  • Nov
    20
    [12:00 PM - 1:00 PM]
    Telomeres and the DNA damage response
    Titia de Lange, Ph.D.
    Leon Hess Professor
    Amercian Cancer Society Professor
    Head, Laboratory of Cell Biology and Genetics
    [SUITE...]
  • Nov
    22
    [1:30 PM - 3:00 PM]
    Understanding the development of Borderline Personality Disorder using genetically informed designs
    Marina A. Bornovalova, PhD
    Associate Professor
    University of South F...
    [SUITE...]
  • Nov
    23
    [12:00 PM - 1:00 PM]
    Negative growth control and survival mechanisms in ovarian cancer cell dormancy
    Fred Dick, Ph.D.
    Professor of Biochemistry and Oncology
    Distinguished Scientist, London ...
    [SUITE...]
  • Nov
    26
    [12:00 PM - 1:00 PM]
    Targeting muscle stem cells to mitigate Duchenne muscular dystrophy
    Nicolas Dumont, Ph.D.
    Assistant Professor
    Rehabilitation Department, Faculty of Medicine
    Ste. J...
    [SUITE...]
Support research at the Lady Davis Institute - Jewish General Hospital